Zevra Therapeutics
ZVRA
ZVRA
58 hedge funds and large institutions have $106M invested in Zevra Therapeutics in 2016 Q1 according to their latest regulatory filings, with 14 funds opening new positions, 20 increasing their positions, 12 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
more funds holding in top 10
Funds holding in top 10: →
24% less capital invested
Capital invested by funds: $139M → $106M (-$32.8M)
Holders
58
Holding in Top 10
2
Calls
–
Puts
–
Top Buyers
| 1 | +$4.61M | |
| 2 | +$1.34M | |
| 3 | +$938K | |
| 4 |
AWA
Arete Wealth Advisors
Chicago,
Illinois
|
+$830K |
| 5 |
BG
BlackRock Group
London,
United Kingdom
|
+$593K |
Top Sellers
| 1 | -$6.27M | |
| 2 | -$1.3M | |
| 3 | -$1.22M | |
| 4 |
Alyeska Investment Group
Chicago,
Illinois
|
-$486K |
| 5 |
MCM
Moore Capital Management
New York
|
-$130K |